| Literature DB >> 34344853 |
Yusuke Nishizawa1, Kaori Kuramitsu1, Masahiro Kido1, Shohei Komatsu1, Hidetoshi Gon1, Takeshi Urade1, Shinichi So1, Jun Ishida1, Sachiyo Shirakawa1, Hironori Yamashita1, Daisuke Tsugawa1, Sachio Terai1, Sadaki Asari1, Hiroaki Yanagimoto1, Hirochika Toyama1, Tetsuo Ajiki1, Takumi Fukumoto1.
Abstract
The prognosis of hepatocellular carcinoma (HCC) presenting with inferior vena cava tumor thrombus (IVCTT) is extremely poor. The aim of this study was to reveal the postoperative course and to identify patients who have survived surgical hepatectomy among HCC patients with IVCTT. Between January 2006 and December 2018, 643 patients underwent surgical hepatectomy for HCC at Kobe University Hospital. Among them, 20 patients were categorized as Vv3 according to the Japanese staging system. We retrospectively collected detailed data on these patients. The statistical, clinical, and pathological data were recorded prospectively and analyzed retrospectively. The median survival time was 9.8 months. Among all patients, 11 (55%) achieved R0 resection, and only two survivors were from this group. The number of tumors (solitary vs. multiple; p=0.050) and pathological Vp (pVp0 vs. other; p=0.009) were identified as risk factors for overall survival in the univariate analysis. In the multivariate analysis, pathological Vp (pVp0 vs. other; p=0.037) was identified as a significant prognostic factor for survival. Pathological Vp affected overall survival among IVCTT patients; the median survival time was 53.7 months with pVp0, 10.2 months with pVp1, and 8.8 months with pVp2-4 (p=0.035). For patients with IVCTT, surgical hepatectomy should be indicated only for those who do not have portal vein invasion and could achieve R0 resection.Entities:
Keywords: Hepatectomy; Hepatocellular carcinoma; Inferior vena cava tumor thrombus; Portal vein tumor thrombus
Mesh:
Year: 2021 PMID: 34344853 PMCID: PMC8622260
Source DB: PubMed Journal: Kobe J Med Sci ISSN: 0023-2513